FAM-TRASTUZUMAB DERUXTECAN Home | Cancer | Solid Tumors | FAM-TRASTUZUMAB DERUXTECAN
FAM-TRASTUZUMAB DERUXTECAN Injection Description Composition Dosage Indications "ENHERTU
(fam-trastuzumab
deruxtecan-nxki)
is
a
HER2-directed
antibody
and
topoisomerase inhibitor conjugate. Fam-trastuzumab deruxtecan-nxki is an antibodydrug conjugate (ADC) composed of three components: 1) a humanized anti-HER2 IgG1 monoclonal antibody (mAb), covalently linked to 2) a topoisomerase inhibitor, via 3) a tetrapeptide-based cleavable linker.Deruxtecan is composed of a protease-cleavable maleimide tetrapeptide linker and the topoisomerase inhibitor, DXd, which is an exatecan derivative.... ENHERTU (fam-trastuzumab deruxtecan-nxki) is a sterile, white to yellowish white, preservative-free lyophilized powder in single-dose vials. Each vial delivers 100 mg of fam-trastuzumab deruxtecan-nxki, L-histidine (4.45 mg), L-histidine hydrochloride monohydrate (20.2 mg), polysorbate 80 (1.5 mg), and sucrose (450 mg). Following reconstitution with 5 mL of Sterile Water for Injection, USP, the resulting concentration of fam-trastuzumab deruxtecan-nxki is 20 mg/mL with a pH of 5.5. The resulting solution is administered by intravenous infusion following dilution. "
Copyright © 2024 ImpoMed
Convert web pages and HTML files to PDF in your applications with the Pdfcrowd HTML to PDF API
Printed with Pdfcrowd.com